000 01455 a2200385 4500
005 20250513074310.0
264 0 _c19931014
008 199310s 0 0 eng d
022 _a0077-8923
024 7 _a10.1111/j.1749-6632.1993.tb55582.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFlanagan, L M
245 0 0 _aArginine vasopressin levels after daily infusions of antisense oligonucleotides into the supraoptic nucleus.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cJul 1993
300 _a520-1 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aArginine Vasopressin
_xantagonists & inhibitors
650 0 4 _aDrug Administration Schedule
650 0 4 _aInjections
650 0 4 _aOligonucleotides, Antisense
_xadministration & dosage
650 0 4 _aOsmolar Concentration
650 0 4 _aOxytocin
_xmetabolism
650 0 4 _aParaventricular Hypothalamic Nucleus
_xmetabolism
650 0 4 _aPituitary Gland
_xmetabolism
650 0 4 _aRats
650 0 4 _aSupraoptic Nucleus
_xmetabolism
650 0 4 _aUrine
_xchemistry
700 1 _aMcCarthy, M M
700 1 _aBrooks, P J
700 1 _aPfaff, D W
700 1 _aMcEwen, B S
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 689
_gp. 520-1
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.1993.tb55582.x
_zAvailable from publisher's website
999 _c8372310
_d8372310